Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2009, p. 2328-2331, Vol. 47, No. 7
0095-1137/09/$08.00+0 doi:10.1128/JCM.00457-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |

Institute for Hygiene and Microbiology, Julius Maximilian University, Würzburg, Germany,1 Allogeneic Stem Cell Transplant Center, Division of Hematology and Oncology Department of Internal Medicine II, Julius Maximilian University, Würzburg, Germany2
Received 4 March 2009/ Returned for modification 7 April 2009/ Accepted 24 April 2009
Daptomycin is a novel lipopeptide antibiotic agent approved for the treatment of gram-positive life-threatening infections. Here we report, for the first time, the isolation of a highly daptomycin-resistant strain of Corynebacterium jeikeium causing a life-threatening infection in a neutropenic patient undergoing cord blood transplantation for secondary acute myeloid leukemia.
Published ahead of print on 6 May 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»